Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

PhoenixBio Co Ltd (6190)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
479.0 +2.0    +0.42%
02/05 - Closed. Currency in JPY ( Disclaimer )
  • Volume: 17,800
  • Bid/Ask: 476.0 / 484.0
  • Day's Range: 467.0 - 487.0
Type:  Equity
Market:  Japan
ISIN:  JP3803010002 
PhoenixBio Co 479.0 +2.0 +0.42%

6190 Balance Sheet

 
Assess the latest PhoenixBio Co Ltd balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced 6190 Annual Report data, financial summaries and charts are available for PhoenixBio Co Ltd investors with their own InvestingPro account.
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 2120 2574 2304 2292
Cash and Short Term Investments 1382 1722 1426 1555
Cash - - - -
Cash & Equivalents 1382 1722 1426 1555
Short Term Investments - - - -
Total Receivables, Net 201 342 341 286
Accounts Receivables - Trade, Net 201 342 341 286
Total Inventory 433 426 439 365
Prepaid Expenses - - - -
Other Current Assets, Total 104 84 98 86
Total Assets 2697 3176 3067 3018
Property/Plant/Equipment, Total - Net 544 557 556 538
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - - - -
Intangibles, Net 4 4 4 5
Long Term Investments 28 39 202 145
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 1 2 1 1
Other Assets, Total 336 168 196 202
Total Current Liabilities 402 1306 1245 1286
Accounts Payable 12 31 48 40
Payable/Accrued - - - -
Accrued Expenses 8 6 1 4
Notes Payable/Short Term Debt 100 - - -
Current Port. of LT Debt/Capital Leases 80 875 875 915
Other Current liabilities, Total 202 394 321 327
Total Liabilities 924 1528 1468 1504
Total Long Term Debt 320 - - 214
Long Term Debt 320 - - -
Capital Lease Obligations - - - 214
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 102 222 223 4
Total Equity 1773 1648 1599 1514
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 2562 2487 2457 2453
Additional Paid-In Capital 782 707 677 673
Retained Earnings (Accumulated Deficit) -1596 -1582 -1568 -1610
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 25 36 33 -2
Total Liabilities & Shareholders' Equity 2697 3176 3067 3018
Total Common Shares Outstanding 4.03 3.75 3.65 3.63
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

6190 Price Commentary

Write your thoughts about PhoenixBio Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email